RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.
Mesci A, Lucien F, Huang X, Wang EH, Shin D, Meringer M, Hoey C, Ray J, Boutros PC, Leong HS, Liu SK.
Mesci A, et al. Among authors: meringer m.
J Transl Med. 2019 Apr 15;17(1):125. doi: 10.1186/s12967-019-1878-3.
J Transl Med. 2019.
PMID: 30987640
Free PMC article.